Stephen M. Strittmatter

Stephen M. Strittmatter was born on August 25, 1958, in St. Louis, Missouri. He completed his undergraduate studies at Harvard College, graduating summa cum laude in 1980 with an A.B. in Biochemistry. He then pursued M.D. and Ph.D. degrees at Johns Hopkins University, completing his studies in 1986 under the mentorship of Solomon H. Snyder. His doctoral research focused on the molecular mechanisms underlying neuronal function. Following his graduate studies, Strittmatter undertook a medical internship and neurology residency at Massachusetts General Hospital (MGH). During his residency, he conducted postdoctoral research with Mark Fishman, investigating the molecular basis of axonal guidance. == Academic career ==

In 1993, Strittmatter joined the faculty of Yale University. He currently holds the positions of Vincent Coates Professor of Neurology and Professor of Neuroscience. Additionally, he serves as the Chair of the Department of Neuroscience and directs several key research initiatives, including: • Kavli Institute for Neuroscience: As director, Strittmatter oversees interdisciplinary research aimed at understanding the complexities of the brain. • '''Yale Alzheimer's Disease Research Center''': Under his leadership, the center focuses on advancing knowledge and treatment strategies for Alzheimer's disease. • Cellular Neuroscience, Neurodegeneration, and Repair Program: This program emphasizes research on neuronal cell function, mechanisms of neurodegeneration, and strategies for neural repair. == Research contributions ==

Strittmatter's research has significantly advanced the understanding of neuronal growth, axonal regeneration, and the pathophysiology of neurodegenerative diseases. His notable contributions include: • Axonal Growth Inhibition: Identifying and characterizing molecules that inhibit axonal growth, such as Nogo-A, and elucidating their roles in limiting neural regeneration following injury. • Therapeutic Targets: Exploring the potential of targeting metabotropic glutamate receptor 5 (mGluR5) and other pathways to mitigate synaptic dysfunction and cognitive decline associated with Alzheimer's disease. == Awards and honors ==

Throughout his career, Strittmatter has received numerous accolades recognizing his contributions to neuroscience, including: • King Faisal Prize for Medicine (2021): Awarded for his outstanding contributions to the understanding of axonal growth failure and limited recovery after spinal cord injury. His work identified the role of the Rho protein in the Nogo protein pathway and its receptor formation, significantly impacting potential strategies for axonal growth recovery. • Zenith Fellows Award (2014): Presented by the Alzheimer's Association, this prestigious award recognized his research on repurposing cancer treatments for Alzheimer's disease. The Zenith Fellows Awards have provided over $48 million to leading Alzheimer's researchers since 1991. • Senator Jacob Javits Neuroscience Investigator Award (2005): Granted by the National Institute of Neurological Disorders and Stroke (NINDS) for his distinguished contributions to neurological science. • Ameritec Award for Spinal Cord Injury Research (2002): Recognized for his innovative work in spinal cord injury research. • McKnight Brain Institute Brain and Memory Disorders Award (2001): Honored for his contributions to understanding brain and memory disorders. • Donaghue Investigator Award (1999): Acknowledged for his promising research in biomedical science. • John Merck Scholar in the Biology of Developmental Disorders in Children (1994): Recognized for his research in developmental disorders. == Personal life ==

Details about Strittmatter's personal life are not widely publicized. His professional focus remains on advancing neuroscience research and mentoring the next generation of scientists and clinicians. == References ==